In a move that’s sure to spark debate among fans, the Baltimore Orioles have brought back a familiar face to their rotation—but is it a risky gamble or a strategic masterstroke? The Orioles have re-signed right-handed pitcher Zach Eflin to a one-year Major League deal, with a mutual option for 2027, marking a reunion that could shape their 2026 season. But here’s where it gets controversial: Eflin’s 2025 season was plagued by injuries, including a right lat strain and chronic lower back issues that required surgery. So, why are the Orioles betting on him again? Let’s dive in.
The deal, valued at a guaranteed $10 million, comes after Eflin’s injury-riddled 2025 campaign, where he posted a 5.93 ERA in just 14 starts. And this is the part most people miss: Despite those struggles, the Orioles see potential in Eflin’s past performance. Before his injuries, he was a key contributor, boasting a 2.60 ERA in nine outings after joining the team in 2024. His leadership and ability to log innings make him a valuable asset—if he can stay healthy.
Eflin’s journey hasn’t been without highlights. His best season came in 2023 with the Tampa Bay Rays, where he went 16-8 with a 3.50 ERA and finished sixth in AL Cy Young Award voting. The Orioles are banking on a return to that form, but it’s a bold move given his recent health concerns. Will it pay off? Only time will tell.
To make room for Eflin, the Orioles designated outfielder Will Robertson for assignment, further reshaping their roster. With Eflin potentially slotting in as the No. 4 starter, the rotation now looks like this: Kyle Bradish, Trevor Rogers, Shane Baz, Eflin, and Dean Kremer, with Tyler Wells possibly shifting to the bullpen. This adds depth to a group that’s already seen significant upgrades this offseason.
But is this the end of the Orioles’ pitching pursuit? Not by a long shot. The team has been linked to top free-agent starters like Framber Valdez and Ranger Suárez, signaling their ambition to compete in 2026. President of baseball operations Mike Elias has made it clear: the Orioles are aiming high.
Eflin himself expressed his love for the clubhouse in mid-August, saying, ‘I love this place. I’d love to be here.’ Now, he’s back for at least one more season—and possibly two. But the question remains: Can he stay healthy and regain his form? Or will his injuries continue to derail his performance?
Here’s the controversial question for you: Is re-signing Eflin a smart move, or are the Orioles setting themselves up for disappointment? Let us know in the comments—we want to hear your take!
